LBX Pharmacy Chain Joint Stock Company (603883.SS)
CNY 18.03
(-1.04%)
CNY 18.03
(-1.04%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.06 Billion CNY | 10.02% |
| 2022 | 2.77 Billion CNY | 16.73% |
| 2021 | 2.37 Billion CNY | 92.24% |
| 2020 | 1.27 Billion CNY | 23.8% |
| 2019 | 1.04 Billion CNY | 24.1% |
| 2018 | 921.57 Million CNY | 24.83% |
| 2017 | 660.37 Million CNY | 20.0% |
| 2016 | 551.75 Million CNY | 23.6% |
| 2015 | 395.82 Million CNY | 11.84% |
| 2014 | 360.02 Million CNY | 22.32% |
| 2013 | 290.92 Million CNY | 19.71% |
| 2012 | 244.83 Million CNY | 40.48% |
| 2011 | 179.65 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 700.16 Million CNY | 34.05% |
| 2024 Q1 | 501.21 Million CNY | -29.86% |
| 2024 Q3 | 256.64 Million CNY | -64.32% |
| 2023 Q2 | 411.2 Million CNY | -9.11% |
| 2023 FY | - CNY | 10.02% |
| 2023 Q4 | 736.36 Million CNY | 201.93% |
| 2023 Q3 | 243.88 Million CNY | -40.69% |
| 2023 Q1 | 452.44 Million CNY | -3.24% |
| 2022 Q1 | 360.95 Million CNY | 22.79% |
| 2022 FY | - CNY | 16.73% |
| 2022 Q4 | 467.59 Million CNY | 83.43% |
| 2022 Q3 | 254.91 Million CNY | -30.94% |
| 2022 Q2 | 369.13 Million CNY | 2.27% |
| 2021 Q4 | 293.96 Million CNY | 42.23% |
| 2021 Q2 | 306.17 Million CNY | -14.26% |
| 2021 Q1 | 357.11 Million CNY | 41.09% |
| 2021 Q3 | 206.68 Million CNY | -32.49% |
| 2021 FY | - CNY | 92.24% |
| 2020 Q3 | 237.07 Million CNY | -3.99% |
| 2020 Q1 | 319.78 Million CNY | 44.04% |
| 2020 Q2 | 246.91 Million CNY | -22.79% |
| 2020 FY | - CNY | 23.8% |
| 2020 Q4 | 253.1 Million CNY | 6.76% |
| 2019 Q3 | 196.24 Million CNY | 4.02% |
| 2019 Q2 | 188.67 Million CNY | -23.81% |
| 2019 Q1 | 247.61 Million CNY | 38.78% |
| 2019 FY | - CNY | 24.1% |
| 2019 Q4 | 222.01 Million CNY | 13.13% |
| 2018 Q3 | 154.73 Million CNY | -5.62% |
| 2018 FY | - CNY | 24.83% |
| 2018 Q4 | 178.42 Million CNY | 15.31% |
| 2018 Q1 | 196.32 Million CNY | 39.89% |
| 2018 Q2 | 163.94 Million CNY | -16.5% |
| 2017 Q1 | 170.63 Million CNY | 23.9% |
| 2017 FY | - CNY | 20.0% |
| 2017 Q4 | 140.34 Million CNY | 10.5% |
| 2017 Q3 | 127.01 Million CNY | 3.11% |
| 2017 Q2 | 123.17 Million CNY | -27.81% |
| 2016 Q2 | 105.64 Million CNY | -6.76% |
| 2016 Q4 | 137.72 Million CNY | 32.41% |
| 2016 FY | - CNY | 23.6% |
| 2016 Q1 | 113.29 Million CNY | -3.5% |
| 2016 Q3 | 104.01 Million CNY | -1.54% |
| 2015 Q4 | 117.4 Million CNY | 75.29% |
| 2015 Q2 | 87.88 Million CNY | -13.36% |
| 2015 Q1 | 101.43 Million CNY | -3.33% |
| 2015 Q3 | 66.97 Million CNY | -23.79% |
| 2015 FY | - CNY | 11.84% |
| 2014 Q2 | 77.07 Million CNY | -12.97% |
| 2014 Q4 | 104.93 Million CNY | 59.65% |
| 2014 Q3 | 65.72 Million CNY | -14.73% |
| 2014 FY | - CNY | 22.32% |
| 2014 Q1 | 88.56 Million CNY | 0.0% |
| 2013 FY | - CNY | 19.71% |
| 2012 FY | - CNY | 40.48% |
| 2011 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 186.51 Million CNY | -1545.706% |
| Jointown Pharmaceutical Group Co., Ltd | 5.08 Billion CNY | 39.619% |
| Yifeng Pharmacy Chain Co., Ltd. | 4.04 Billion CNY | 24.184% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 1.53 Billion CNY | -99.448% |